MoneyWorks4Me

Pharmaids Pharmaceuticals informs about allotment of equity shares

02 Mar 2024 Evaluate
Pharmaids Pharmaceuticals has informed that Board of Directors of the Company at its meeting held on March 02, 2024 approved the allotment of 12856578 fully paid-up Equity Shares for the Consideration other than cash on Preferential Basis by way of Private Placement. The details as required under Regulation 30 of Listing Regulations read with SEBI Circular dated July 13, 2023 are given in the attached intimation.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..